参考文献
[1] Jun JI,Lau LF. Taking aim at the extracellular matrix: CCN proteins
as emerging therapeutic targets[J]. Nat Rev Drug Discov,2011,
10(12):945-963.
[2] Conlon GA,Murray GI. Recent advances in understanding the roles
of matrix metalloproteinases in tumour invasion and metastasis[J].
J Pathol,2019,247(5):629-640.
[3] Yu-ting Huang,Qiang Lan,Girieca Lorusso,et al. The matricellular
protein Cyr61 promotes breast cancer lung metastasis by facilitating
tumor cell extravasation and suppressing anoikis.[J]. Oncotarget,
2017,8(6):9200-9215.
[4] Reid SE,Zanivan S. Tumor stiffness extends its grip on the metastatic
microenvironment[J]. Mol Cell Oncol. 2017,4(6):1-2.
[5] Gialeli C,Theocharis AD,Karamanos NK. Roles of matrix metalloproteinases
in cancer progression and their pharmacological targeting[J]. FEBS J,
2011,278(1):16-27.
[6] Fuksiewicz M. The matrix metalloproteinase-7 and pro-enzyme of
metalloproteinase-1 as a potential marker for patients with rectal
cancer without distant metastasis[J]. Tumor Biol,2015,36(5):
3629-3635.
[7] LF Lau. CCN1/Cyr61:The very model of a modern matricellular protein
[J]. Cell Mol Life Sci,2011,68(19): 3149-3163.
[8] Chen Y,Du XY. Functional properties and intracellular signaling of
CCN1/Cyr61[J]. J Cell Biochem,2007,100(6):1337-1345.
|